Ad is loading...
GSVPX
Price
$17.49
Change
-$0.17 (-0.96%)
Updated
Nov 15 closing price
VMCIX
Price
$74.52
Change
-$0.41 (-0.55%)
Updated
Nov 15 closing price
Ad is loading...

GSVPX vs VMCIX

Header iconGSVPX vs VMCIX Comparison
Open Charts GSVPX vs VMCIXBanner chart's image
Goldman Sachs Small/Mid Cap Value P
Price$17.49
Change-$0.17 (-0.96%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index Institutional
Price$74.52
Change-$0.41 (-0.55%)
VolumeN/A
CapitalizationN/A
GSVPX vs VMCIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GSVPX vs. VMCIX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSVPX is a StrongSell and VMCIX is a Buy.

FUNDAMENTALS
Fundamentals
VMCIX has more cash in the bank: 175B vs. GSVPX (152M). VMCIX pays higher dividends than GSVPX: VMCIX (1.50) vs GSVPX (0.87). GSVPX was incepted earlier than VMCIX: GSVPX (7 years) vs VMCIX (27 years). GSVPX is a more actively managed with annual turnover of: 56.00 vs. VMCIX (13.00). GSVPX has a lower initial minimum investment than VMCIX: GSVPX (0) vs VMCIX (5000000). VMCIX (28.30) and GSVPX (27.59) have marching annual gain over last year. VMCIX return over 5 years is better than : 59.03 vs. GSVPX (39.75).
GSVPXVMCIXGSVPX / VMCIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years27 years-
Gain YTD14.76417.34085%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets152M175B0%
Annual Yield % from dividends0.871.5058%
Returns for 1 year27.5928.3097%
Returns for 3 years-5.575.05-110%
Returns for 5 years39.7559.0367%
Returns for 10 yearsN/A128.04-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DEC14.350.20
+1.41%
Diversified Energy Company plc
CVNA241.000.56
+0.23%
Carvana Co
FA17.50-0.35
-1.96%
First Advantage Corp
TTNP3.81-0.19
-4.64%
Titan Pharmaceuticals
INMB4.95-0.48
-8.92%
INmune Bio